Search

Your search keyword '"Ma, Yussanne"' showing total 439 results

Search Constraints

Start Over You searched for: Author "Ma, Yussanne" Remove constraint Author: "Ma, Yussanne" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
439 results on '"Ma, Yussanne"'

Search Results

1. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes.

2. A platform for oncogenomic reporting and interpretation

3. Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer

4. The Integrated Genomic Landscape of Thymic Epithelial Tumors

5. A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases

6. The whole-genome landscape of medulloblastoma subtypes

7. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

8. Integrated Molecular Characterization of Uterine Carcinosarcoma

9. Integrated genomic and molecular characterization of cervical cancer

10. Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia.

11. miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

12. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

13. Comprehensive genomic profiling of glioblastoma tumors, BTICs, and xenografts reveals stability and adaptation to growth environments

14. RETRACTED ARTICLE: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma

15. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer

16. Whole genome and transcriptome integrated analyses guide clinical care of pediatric poor prognosis cancers.

17. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

18. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

19. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

20. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

21. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

22. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

23. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

24. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

25. Driver Fusions and Their Implications in the Development and Treatment of Human Cancers

26. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas

27. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types

28. Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma

29. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions

30. The genetic basis and cell of origin of mixed phenotype acute leukaemia

31. Table S6 from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

32. Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

33. Supplementary Data from Integrative Molecular Characterization of Malignant Pleural Mesothelioma

34. Supplementary File 1 from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma

35. Supplementary Figure S3 from Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation

36. Supplementary Table S1 from Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation

37. Supplementary Materials and Methods from Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation

38. Supplementary Table 5 from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer

39. Data from Pyruvate Kinase Inhibits Proliferation during Postnatal Cerebellar Neurogenesis and Suppresses Medulloblastoma Formation

40. Supplementary File 2 from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma

41. Supplemental Table S2: Clinicopathological features of 118 DAWTs from Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

42. Supplemental Table S1: TP53 variants identified in 118 DAWTs by WGS or WES from Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

43. Supplementary Methods and Data from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma

44. Supplementary Information from Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer

45. Supplemental Table S4: Probe sequences used for MLPA from Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

46. Supplemental Table S3: Recurrent mutations and segmental copy losses or gains identified in 39 DAWTs from Significance of TP53 Mutation in Wilms Tumors with Diffuse Anaplasia: A Report from the Children's Oncology Group

47. Data from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma

48. Supplementary File 3 from Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma

49. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

50. Combined burden and functional impact tests for cancer driver discovery using DriverPower

Catalog

Books, media, physical & digital resources